Precigen

About:

Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.

Website: https://precigen.com

Twitter/X: precigen

Top Investors: Third Security, Randal J. Kirk, NewVa Capital Partners

Description:

Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.